Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial — PEDITREC

Cardiopulmonary Bypass Surgery Clinical Trial

Official title:
Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial

Status Terminated

Clinical Trial Summary

This study is testing whether pathogen reduced platelets can control bleeding as well as non-pathogen reduced platelets (otherwise known as large volume delayed sampling).

Clinical Trial Description

This is a pilot clinical trial to assess the post-operative bleeding in children who receive pathogen-reduced (PR) platelet transfusions versus standard (large volume delayed sampling - LVDS) platelet transfusions both during and for 24 hours following cardiopulmonary bypass surgery. ;

Study Design

Related Conditions & MeSH terms

Cardiopulmonary Bypass Surgery

Clinical Trial Details

NCT number	NCT05293106
Study type	Interventional
Source	Weill Medical College of Cornell University
Contact
Status	Terminated
Phase	Phase 4
Start date	July 5, 2022
Completion date	September 27, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05083403` - HPI (Hypotension Prediction Index) Care Trial	N/A
Completed	`NCT05184725` - CARINAE for Stress Relief in Perioperative Care	N/A
Completed	`NCT03861286` - Haemostatic Markers in Cardiopulmonary Bypass